Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1898 1
1927 1
1931 1
1935 1
1939 1
1940 1
1945 4
1946 6
1947 5
1948 10
1949 6
1950 12
1951 5
1952 13
1953 13
1954 5
1955 11
1956 7
1957 6
1958 9
1959 8
1960 9
1961 6
1962 13
1963 24
1964 38
1965 25
1966 21
1967 46
1968 42
1969 49
1970 54
1971 50
1972 54
1973 58
1974 70
1975 68
1976 82
1977 77
1978 83
1979 80
1980 79
1981 84
1982 96
1983 101
1984 110
1985 119
1986 122
1987 127
1988 131
1989 146
1990 141
1991 137
1992 141
1993 169
1994 160
1995 187
1996 163
1997 192
1998 197
1999 204
2000 201
2001 187
2002 202
2003 227
2004 200
2005 253
2006 246
2007 279
2008 302
2009 324
2010 362
2011 386
2012 405
2013 415
2014 441
2015 443
2016 439
2017 418
2018 462
2019 462
2020 550
2021 617
2022 628
2023 538
2024 546
2025 612
2026 57

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,003 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Emerging therapies in Ewing sarcoma.
Strauss SJ, Berlanga P, McCabe MG. Strauss SJ, et al. Curr Opin Oncol. 2024 Jul 1;36(4):297-304. doi: 10.1097/CCO.0000000000001048. Epub 2024 May 22. Curr Opin Oncol. 2024. PMID: 38775200 Free PMC article. Review.
PURPOSE OF REVIEW: There is an unmet need to improve outcomes for patients for Ewing sarcoma, a rare, aggressive sarcoma with a peak incidence in adolescents and young adults (AYA). ...RECENT FINDINGS: Improved understanding of Ewing sarcoma bio …
PURPOSE OF REVIEW: There is an unmet need to improve outcomes for patients for Ewing sarcoma, a rare, aggressive sarcoma
Review: Ewing Sarcoma Predisposition.
Gargallo P, Yáñez Y, Juan A, Segura V, Balaguer J, Torres B, Oltra S, Castel V, Cañete A. Gargallo P, et al. Pathol Oncol Res. 2020 Oct;26(4):2057-2066. doi: 10.1007/s12253-019-00765-3. Epub 2019 Oct 26. Pathol Oncol Res. 2020. PMID: 31656020 Free article. Review.
Ewing sarcoma is a rare tumor developed in bone and soft tissues of children and teenagers. ...This review summarizes the available evidence on predisposing factors involved in Ewing sarcoma susceptibility. On the basis of these data, an integrated app
Ewing sarcoma is a rare tumor developed in bone and soft tissues of children and teenagers. ...This review summarizes the avai
Ewing sarcoma.
Choi EY, Gardner JM, Lucas DR, McHugh JB, Patel RM. Choi EY, et al. Semin Diagn Pathol. 2014 Jan;31(1):39-47. doi: 10.1053/j.semdp.2014.01.002. Epub 2014 Jan 5. Semin Diagn Pathol. 2014. PMID: 24680181 Review.
The purpose of this article is to review the clinical, radiological, histologic, and molecular features of Ewing sarcoma and to provide a discussion of the differential diagnosis of small round cell tumors of bone....
The purpose of this article is to review the clinical, radiological, histologic, and molecular features of Ewing sarcoma and t …
Ewing sarcoma and Ewing-like tumors.
Sbaraglia M, Righi A, Gambarotti M, Dei Tos AP. Sbaraglia M, et al. Virchows Arch. 2020 Jan;476(1):109-119. doi: 10.1007/s00428-019-02720-8. Epub 2019 Dec 4. Virchows Arch. 2020. PMID: 31802230 Review.
Ewing sarcoma (ES) and Ewing-like sarcomas are highly aggressive round cell mesenchymal neoplasms, most often occurring in children and young adults. ...A granular diagnostic approach to Ewing sarcoma and Ewing-like sarcomas is justified
Ewing sarcoma (ES) and Ewing-like sarcomas are highly aggressive round cell mesenchymal neoplasms, most often occurring
Ewing sarcoma: investigational mono- and combination therapies in clinical trials.
Gartrell J, Rodriguez-Galindo C. Gartrell J, et al. Expert Opin Investig Drugs. 2021 Jun;30(6):653-663. doi: 10.1080/13543784.2021.1919623. Epub 2021 Jun 3. Expert Opin Investig Drugs. 2021. PMID: 33870845 Review.
INTRODUCTION: Over the last decades, multi-institutional clinical trials have resulted in significant improvements in the outcomes of patients with localized Ewing sarcoma; however, those with metastatic and recurrent diseases continue to fare poorly. ...Here we rev …
INTRODUCTION: Over the last decades, multi-institutional clinical trials have resulted in significant improvements in the outcomes of patien …
Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting Cells.
Visser LL, Bleijs M, Margaritis T, van de Wetering M, Holstege FCP, Clevers H. Visser LL, et al. Cancer Res Commun. 2023 Oct 24;3(10):2158-2169. doi: 10.1158/2767-9764.CRC-23-0027. Cancer Res Commun. 2023. PMID: 37823774 Free PMC article.
Here, we explore the immune microenvironment of Ewing sarcoma, by single-cell RNA sequencing of 18 Ewing sarcoma primary tissue samples. ...Interaction analysis reveals a clear role for Ewing sarcoma tumor cells in turning the Ewing
Here, we explore the immune microenvironment of Ewing sarcoma, by single-cell RNA sequencing of 18 Ewing sarcoma
Outcome of Scapular Ewing Sarcoma.
Hargiss JB, Labott JR, Broida SE, Rose PS, Barlow JD, Houdek MT. Hargiss JB, et al. Anticancer Res. 2022 Aug;42(8):3869-3872. doi: 10.21873/anticanres.15879. Anticancer Res. 2022. PMID: 35896233 Review.
BACKGROUND/AIM: Ewing sarcoma is a common primary bone tumor, often located in the distal femur or pelvis. ...PATIENTS AND METHODS: We reviewed 9 patients with an Ewing sarcoma of the scapula, which included 5 males and 4 females with a mean age of 196 …
BACKGROUND/AIM: Ewing sarcoma is a common primary bone tumor, often located in the distal femur or pelvis. ...PATIENTS AND MET …
Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents.
Setty BA, Gikandi A, DuBois SG. Setty BA, et al. Paediatr Drugs. 2023 Jul;25(4):389-397. doi: 10.1007/s40272-023-00568-9. Epub 2023 Apr 4. Paediatr Drugs. 2023. PMID: 37014523 Review.
Ewing sarcoma is a translocation-associated sarcoma mainly impacting adolescents and young adults. ...Finally, we provide an overview of chemotherapy regimens and targeted therapies used in the management of patients with recurrent Ewing sarcoma
Ewing sarcoma is a translocation-associated sarcoma mainly impacting adolescents and young adults. ...Finally, we provi
Updates on WHO classification for small round cell tumors: Ewing sarcoma vs. everything else.
Dehner CA, Lazar AJ, Chrisinger JSA. Dehner CA, et al. Hum Pathol. 2024 May;147:101-113. doi: 10.1016/j.humpath.2024.01.007. Epub 2024 Jan 26. Hum Pathol. 2024. PMID: 38280658 Free article. Review.
The WHO Classification of Soft Tissue and Bone Tumours currently recognizes four categories of undifferentiated small round cell sarcoma: Ewing sarcoma, round cell sarcoma with EWSR1-non-ETS fusions including NFATc2 and PATZ1, CIC-rearranged sarcoma
The WHO Classification of Soft Tissue and Bone Tumours currently recognizes four categories of undifferentiated small round cell sarcoma
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Italiano A, Mir O, Mathoulin-Pelissier S, Penel N, Piperno-Neumann S, Bompas E, Chevreau C, Duffaud F, Entz-Werlé N, Saada E, Ray-Coquard I, Lervat C, Gaspar N, Marec-Berard P, Pacquement H, Wright J, Toulmonde M, Bessede A, Crombe A, Kind M, Bellera C, Blay JY. Italiano A, et al. Lancet Oncol. 2020 Mar;21(3):446-455. doi: 10.1016/S1470-2045(19)30825-3. Epub 2020 Feb 17. Lancet Oncol. 2020. PMID: 32078813 Free PMC article. Clinical Trial.
FINDINGS: Between April 16, 2015, and July 12, 2018, 90 patients (45 with Ewing sarcoma 45 with osteosarcoma) were recruited to the study. Median follow-up was 31.3 months (95% CI 12.4-35.4) for patients with Ewing sarcoma and 31.1 months (24.4-31.7) f …
FINDINGS: Between April 16, 2015, and July 12, 2018, 90 patients (45 with Ewing sarcoma 45 with osteosarcoma) were recruited t …
13,003 results
You have reached the last available page of results. Please see the User Guide for more information.